CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 178 enrolled
Drug / intervention
TactiCath Quartz treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02310100
NCT02310100N/ACompleted
CompareCT.gov

TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study

Abbott Medical Devices·interventional·Posted Dec 5, 2014·Updated Oct 12, 2021

In Brief

A clinical study evaluating TactiCath Quartz treatment for Paroxysmal Atrial Fibrillation. Completed, enrolled 178 participants across 20 sites.

Detailed Summary

A prospective, multicenter, interventional study to collect confirmatory evidence on the safety and effectiveness of the TactiCath® percutaneous ablation catheter in the post approval setting for the treatment of symptomatic paroxysmal atrial fibrillation using contact force assisted irrigated radiofrequency ablation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParoxysmal Atrial Fibrillation
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 5, 2014
Enrollment StartJan 21, 2015
Primary CompletionFeb 1, 2017
Study CompletionSep 17, 2021
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 11.6 years ago

Interventions

TactiCath Quartz treatmentdevice